UBS Downgrades Diageo (DEO), Flags Risks in U.S. Spirits Market
Diageo plc (NYSE:DEO) is included among the 11 Worst Performing Dividend Stocks Year-to-Date. On December 3, UBS downgraded Diageo plc (NYSE:DEO) to Neutral from Buy and also trimmed the stock’s price target to 1,850 GBp from 2,250 GBp. The analyst noted the stock’s share price decline this year and sees continued downside risks in the US […]
SeedMedical Hong Kong Launches Evidence-Based Weight Management Program Introducing GLP-1 Technology for Scientific Weight Reduction
Post Content
Wave Life Sciences Ltd. (WVE): A Bull Case Theory
We came across a bullish thesis on Wave Life Sciences Ltd. on Valueinvestorsclub.com by zamperini. In this article, we will summarize the bulls’ thesis on WVE. Wave Life Sciences Ltd.’s share was trading at $7.41 as of December 1st. Photo by Toon Lambrechts on Unsplash Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic […]
How the rise of GLP-1 drugs is shifting consumer habits
The rise in the use of GLP-1 weight-loss drugs across the U.S. is shifting not only scales, but also how Americans are spending their time and money. Washington Post retail reporter Jaclyn Peiser explains. CBS News 24/7 is the premier anchored streaming news service from CBS News and Stations that is available free to everyone […]
Structure Therapeutics Inc. (GPCR) Discusses Topline Results from ACCESS Program of Oral Small Molecule GLP-1 Receptor Agonist Transcript
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk, research shows
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.
The miracle that fades: New study reveals troubling reality of post-treatment weight regain
(NaturalNews) A large-scale study of over 1.2 million patients found that more than half (58%) of those who stop GLP-1 weight-loss drugs like Wegovy and Ozempic…
Prompting Models to Obfuscate Their CoT
Published on December 8, 2025 9:00 PM GMT Summary: Models can sometimes obfuscate their CoT when prompted to do so on a basic reasoning task We can increase the rate of obfuscation by telling the model it failed previously Obfuscation doesn’t significantly decrease task performance Models display interesting strategies to avoid saying “taboo” terms: Minimizing […]
Weight-loss drug customers were caught up in telehealth scam. Here’s how to avoid being a victim
Federal Trade Commission crackdown on company selling GLP-1 is a reminder of the dangers consumers face when purchasing trending treatments online
Rising Malnutrition Risks Spark Push for Plant-Based Diets Among Ozempic Users
GLP-1 weight loss medications like Ozempic, Mounjaro, and Wegovy are rapidly growing in popularity. In fact, research from KFF last year found that about one in eight Americans had either used or were currently using a GLP-1 weight loss drug. The surge in popularity has been especially noticeable in Hollywood, where stars such as Meghan […]